British Pharmacopoeia(redirected from British Pharmacopoeia Commission)
Also found in: Wikipedia.
Pharmacopeia, Pharmacopoeia (far'mă-kō-pē'ă),
A work containing monographs of therapeutic agents, standards for their strength and purity, and their formulations. The various national pharmacopeias are referred to by abbreviations, of which the following are the most frequently encountered: USP, the Pharmacopeia of the United States of America (United States Pharmacopeia); BP, British Pharmacopoeia; Codex medicamentarius, the French Pharmacopeia; I.C. Add. (or BA), the Indian and Colonial Addendum to the BP; IP, International Pharmacopeia; Pharmacopeia Austr., the Austrian Pharmacopeia; Ph.G., the German Pharmacopeia (D.A.B.); Pharmacopeia Helv., the Swiss Pharmacopeia. The first edition of the USP was compiled in 1820 and was made a legal standard by the terms of the National Food and Drugs Act in January 1907.
[G. pharmakopoiia, fr. pharmakon, a medicine, + poieo, to make]
British Pharmacopoeia (BP)
the official British reference work setting forth standards of strength and purity of medications and containing directions for their preparation to ensure that the same prescription written by different doctors and filled by different pharmacists will contain exactly the same ingredients in the same proportions. The first British Pharmacopoeia was published in 1864 by the General Medical Council; it superseded the London Pharmacopoeia, which had been published since 1618. See also British Medical Association, United States Pharmacopeia.
British pharmacopoeia (briˑ·tish farˈ·m·k·pēˑ·),
n.pr a list compiled by experts in pharmacology and pharmacy and approved by the government of Great Britain that provides specifications of the characteristics, manufacture, use, and dosage of drugs.
a publication of the General Medical Council (UK) describing and establishing standards for medicines, preparations, materials and articles used in the practice of medicine, surgery and midwifery.